| Year |
Citation |
Score |
| 2022 |
Schneider-Hohendorf T, Gerdes LA, Pignolet B, Gittelman R, Ostkamp P, Rubelt F, Raposo C, Tackenberg B, Riepenhausen M, Janoschka C, Wünsch C, Bucciarelli F, Flierl-Hecht A, Beltrán E, Kümpfel T, ... ... Brassat D, et al. Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. The Journal of Experimental Medicine. 219. PMID 36048016 DOI: 10.1084/jem.20220650 |
0.317 |
|
| 2021 |
Fissolo N, Pignolet B, Rio J, Vermersch P, Ruet A, deSèze J, Labauge P, Vukusic S, Papeix C, Martinez-Almoyna L, Tourbah A, Clavelou P, Moreau T, Pelletier J, Lebrun-Frenay C, ... ... Brassat D, et al. Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab. Neurology(R) Neuroimmunology & Neuroinflammation. 8. PMID 33903203 DOI: 10.1212/NXI.0000000000001003 |
0.309 |
|
| 2021 |
Ostkamp P, Salmen A, Pignolet B, Görlich D, Andlauer TFM, Schulte-Mecklenbeck A, Gonzalez-Escamilla G, Bucciarelli F, Gennero I, Breuer J, Antony G, Schneider-Hohendorf T, Mykicki N, Bayas A, Then Bergh F, ... ... Brassat D, et al. Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33376202 DOI: 10.1073/pnas.2018457118 |
0.331 |
|
| 2020 |
Cohen M, Mondot L, Bucciarelli F, Pignolet B, Laplaud DA, Wiertlewski S, Brochet B, Ruet A, Defer G, Derache N, Vermersch P, Zephir H, Debouverie M, Mathey G, Berger E, ... ... Brassat D, et al. BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520969145. PMID 33124504 DOI: 10.1177/1352458520969145 |
0.317 |
|
| 2018 |
Albrecht P, Bjørnå IK, Brassat D, Farrell R, Feys P, Hobart J, Hupperts R, Linnebank M, Magdič J, Oreja-Guevara C, Pozzilli C, Salgado AV, Ziemssen T. Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting. Therapeutic Advances in Neurological Disorders. 11: 1756286418803248. PMID 30305850 DOI: 10.1177/1756286418803248 |
0.325 |
|
| 2018 |
Bernard-Valnet R, Pignolet B, Biotti D, Ciron J, Lafontan JF, Dumas H, Bonneville F, Brassat D. Unexpected high multiple sclerosis activity after switching from fingolimod to alemtuzumab. Multiple Sclerosis and Related Disorders. 25: 216-218. PMID 30114625 DOI: 10.1016/j.msard.2018.08.006 |
0.322 |
|
| 2017 |
Fissolo N, Pignolet B, Matute-Blanch C, Triviño JC, Miró B, Mota M, Perez-Hoyos S, Sanchez A, Vermersch P, Ruet A, de Sèze J, Labauge P, Vukusic S, Papeix C, Almoyna L, ... ... Brassat D, et al. MMP9 is decreased in natalizumab-treated MS patients at risk for PML. Annals of Neurology. PMID 28681388 DOI: 10.1002/ana.24987 |
0.348 |
|
| 2017 |
Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, et al. Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome. Neurology(R) Neuroimmunology & Neuroinflammation. 4: e346. PMID 28616447 DOI: 10.1212/NXI.0000000000000346 |
0.301 |
|
| 2016 |
Pivot D, Debouverie M, Grzebyk M, Brassat D, Clanet M, Clavelou P, Confavreux C, Edan G, Leray E, Moreau T, Vukusic S, Hédelin G, Guillemin F. Geographical Heterogeneity of Multiple Sclerosis Prevalence in France. Plos One. 11: e0167556. PMID 27936086 DOI: 10.1371/journal.pone.0167556 |
0.314 |
|
| 2012 |
Michel L, Foucher Y, Vukusic S, Confavreux C, De Sèze J, Brassat D, Clanet M, Clavelou P, Ouallet JC, Brochet B, Pelletier J, Labauge P, Lebrun C, Lepage E, Le Frere F, et al. Increased risk of multiple sclerosis relapse after in vitro fertilisation Journal of Neurology, Neurosurgery and Psychiatry. 83: 796-802. PMID 22693287 DOI: 10.1136/Jnnp-2012-302235 |
0.319 |
|
| 2011 |
Lebrun C, Vermersch P, Brassat D, Defer G, Rumbach L, Clavelou P, Debouverie M, De Seze J, Wiertlevsky S, Heinzlef O, Tourbah A, Fromont A, Frenay M. Cancer and multiple sclerosis in the era of disease-modifying treatments Journal of Neurology. 258: 1304-1311. PMID 21293872 DOI: 10.1007/s00415-011-5929-9 |
0.3 |
|
| 2010 |
Lebrun C, Blanc F, Brassat D, Zephir H, de Seze J. Cognitive function in radiologically isolated syndrome. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 919-25. PMID 20610492 DOI: 10.1177/1352458510375707 |
0.312 |
|
| 2010 |
Brassat D. [Pathophysiology of multiple sclerosis]. Presse Medicale (Paris, France : 1983). 39: 341-8. PMID 20171040 DOI: 10.1016/j.lpm.2009.12.001 |
0.343 |
|
| 2009 |
Vandenbroeck K, Comabella M, Tolosa E, Goertsches R, Brassat D, Hintzen R, Infante-Duarte C, Favorov A, Escorza S, Palacios R, Oksenberg JR, Villoslada P. United Europeans for development of pharmacogenomics in multiple sclerosis network. Pharmacogenomics. 10: 885-94. PMID 19450134 DOI: 10.2217/Pgs.09.33 |
0.356 |
|
| 2009 |
Couturier N, Gourraud PA, Cournu-Rebeix I, Gout C, Bucciarelli F, Edan G, Babron MC, Clerget-Darpoux F, Clanet M, Fontaine B, Brassat D. IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients. European Journal of Human Genetics : Ejhg. 17: 844-7. PMID 19156166 DOI: 10.1038/ejhg.2008.259 |
0.333 |
|
| 2004 |
Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, et al. A second-generation genomic screen for multiple sclerosis. American Journal of Human Genetics. 75: 1070-8. PMID 15494893 DOI: 10.1086/426459 |
0.304 |
|
| 2004 |
Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, et al. Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Annals of Neurology. 55: 793-800. PMID 15174013 DOI: 10.1002/Ana.20092 |
0.347 |
|
| 2004 |
Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Cournu-Rebeix I, Azoulay-Cayla A, Lyon-Caen O, Fontaine B, Duhamel E, Coppin H, Brassat D, et al. Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study. Neurogenetics. 5: 45-8. PMID 14595552 DOI: 10.1007/S10048-003-0163-Y |
0.307 |
|
| Show low-probability matches. |